| Target Species |
Dogs |
| Active Substances |
Imidacloprid |
| Pharmaceutical Form |
Spot-on solution |
| Therapeutic Group |
Ectoparasiticide |
| Authorisation Route |
National |
| Legal Category |
AVM-GSL |
| Controlled Drug Status |
Not a controlled drug |
| Marketing Authorisation Holder |
Elanco Europe Ltd |
| Distributors |
<span>Bob Martin (UK) Ltd</span><br /><br /><span>Elanco Europe Ltd</span> |
| Territory |
United Kingdom |
| SPC |
Advantage 400 mg Spot-on Solution for Extra Large Dogs SPC |
| UKPAR |
Advantage 400 mg Spot-on Solution for Extra Large Dogs UKPAR |
